Synovial PMN show a coordinated up-regulation of CD66 molecules.
Changes in the expression of various activation-dependent surface markers have been reported for polymorphonuclear neutrophils (PMN) isolated from synovial fluid of patients with inflammatory joint diseases. We extend these findings to the expression of CD66 molecules and several other surface markers. Three members of the CD66 family, namely CD66a, CD66b, and CD66c, showed an up to fourfold up-regulation on synovial fluid PMN compared with peripheral blood PMN (PBG) of the same patients; CD59 was increased twofold, the expression of CD16 did not change, whereas CD62L was reduced by more than 50% on synovial fluid PMN. It is interesting that CD66a, CD66b, and CD66c showed a coordinated expression on PBG of patients and controls and a coordinated up-regulation on synovial neutrophils. In contrast, after in vitro stimulation of peripheral blood PMN with phorbol myristate acetate, CD66c was much less up-regulated compared with CD66a and CD66b. All samples of synovial fluid PMN exhibited an additional increase in the expression of CD66a, CD66b, and CD66c when stimulated with phorbol myristate acetate in vitro. Prostaglandins are known to inhibit various responses of neutrophils to inflammatory stimuli. We could show that prostaglandins inhibit N-formyl-methionyl-leucyl-phenylalanine-induced up-regulation of CD66 on peripheral blood PMN in a concentration-dependent manner.
Hönig
M
M
Institute of Immunobiology, University of Freiburg, Germany.
Peter
H H
HH
Jantscheff
P
P
Grunert
F
F
D000328:Adult; D000368:Aged; D000527:Alprostadil / Q000494:pharmacology; D015703:Antigens, CD / Q000096:biosynthesis* / Q000235:genetics; D000943:Antigens, Differentiation / Q000096:biosynthesis* / Q000235:genetics; D001168:Arthritis / Q000276:immunology / Q000473:pathology; D015535:Arthritis, Psoriatic / Q000276:immunology / Q000473:pathology; D016918:Arthritis, Reactive / Q000276:immunology / Q000473:pathology; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000473:pathology; D018957:CD59 Antigens / Q000096:biosynthesis / Q000235:genetics; D015815:Cell Adhesion Molecules; D015232:Dinoprostone / Q000494:pharmacology; D005260:Female; D005434:Flow Cytometry; D005786:Gene Expression Regulation / Q000187:drug effects; D017261:Glycosylphosphatidylinositols / Q000096:biosynthesis / Q000235:genetics; D006801:Humans; D019041:L-Selectin / Q000096:biosynthesis / Q000235:genetics; D008297:Male; D008875:Middle Aged; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism*; D020033:Protein Isoforms / Q000096:biosynthesis* / Q000235:genetics; D017452:Receptors, IgG / Q000032:analysis; D013582:Synovial Fluid / Q000166:cytology / Q000276:immunology*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D015703:Antigens, CD; D000943:Antigens, Differentiation; D018957:CD59 Antigens; C069847:CD66 antigens; D015815:Cell Adhesion Molecules; D017261:Glycosylphosphatidylinositols; D020033:Protein Isoforms; D017452:Receptors, IgG; D019041:L-Selectin; D009240:N-Formylmethionine Leucyl-Phenylalanine; D000527:Alprostadil; D015232:Dinoprostone; D013755:Tetradecanoylphorbol Acetate